Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

ABRAXANE

Date 27 January 2010
Pharmaceutical
formulation

ABRAXANE 5 mg/ml, powder for suspension for infusion
B/1 100 mg vial (CIP: 384 418-7)

ATC code
  1. L01CD01
Active ingredient

paclitaxel
Laboratory / Manufacturer ABRAXIS BIOSCIENCE SAS
Reason for request Inclusion on the list of medicines approved for use by hospitals.

Documents

Tools

For more information

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Breast cancers - Drug therapy
Haute Autorité de Santé - 2009